COX7C

gene
On this page

Summary

COX7C (cytochrome c oxidase subunit 7C, HGNC:2292) is a protein-coding gene on chromosome 5q14.3, encoding Cytochrome c oxidase subunit 7C, mitochondrial (P15954). Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. It is a selective cancer dependency (DepMap: 81.8% of cell lines).

Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes subunit VIIc, which shares 87% and 85% amino acid sequence identity with mouse and bovine COX VIIc, respectively, and is found in all tissues. A pseudogene COX7CP1 has been found on chromosome 13.

Source: NCBI Gene 1350 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 17 total
  • Cancer dependency (DepMap): dependent in 81.8% of screened cell lines
  • MANE Select transcript: NM_001867

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:2292
Approved symbolCOX7C
Namecytochrome c oxidase subunit 7C
Location5q14.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000127184
Ensembl biotypeprotein_coding
OMIM603774
Entrez1350

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 10 protein_coding, 4 protein_coding_CDS_not_defined

ENST00000247655, ENST00000505430, ENST00000509578, ENST00000510447, ENST00000511472, ENST00000513124, ENST00000515763, ENST00000900830, ENST00000900831, ENST00000927184, ENST00000927185, ENST00000927186, ENST00000927187, ENST00000927188

RefSeq mRNA: 1 — MANE Select: NM_001867 NM_001867

CCDS: CCDS4063

Canonical transcript exons

ENST00000247655 — 3 exons

ExonStartEnd
ENSE000009987348661794186618130
ENSE000009987358662066886620962
ENSE000034922918661935386619496

Expression profiles

Bgee: expression breadth ubiquitous, 296 present calls, max score 99.82.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 351.2982 / max 4860.3445, expressed in 1827 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
57439318.13831827
5744011.89081753
5744110.66911675
574428.23341596
2036162.36661210

Top tissues by expression

296 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
heart right ventricleUBERON:000208099.82gold quality
right atrium auricular regionUBERON:000663199.82gold quality
cardiac atriumUBERON:000208199.80gold quality
cardiac ventricleUBERON:000208299.80gold quality
heart left ventricleUBERON:000208499.80gold quality
apex of heartUBERON:000209899.79gold quality
heartUBERON:000094899.77gold quality
hindlimb stylopod muscleUBERON:000425299.77gold quality
adult mammalian kidneyUBERON:000008299.73gold quality
prefrontal cortexUBERON:000045199.73gold quality
ganglionic eminenceUBERON:000402399.72gold quality
biceps brachiiUBERON:000150799.71gold quality
mucosa of transverse colonUBERON:000499199.70gold quality
cortical plateUBERON:000534399.70gold quality
dorsolateral prefrontal cortexUBERON:000983499.70gold quality
anterior cingulate cortexUBERON:000983599.70gold quality
caudate nucleusUBERON:000187399.69gold quality
cingulate cortexUBERON:000302799.69gold quality
muscle of legUBERON:000138399.68gold quality
nucleus accumbensUBERON:000188299.68gold quality
right frontal lobeUBERON:000281099.68gold quality
metanephros cortexUBERON:001053399.68gold quality
Brodmann (1909) area 9UBERON:001354099.68gold quality
gastrocnemiusUBERON:000138899.67gold quality
adenohypophysisUBERON:000219699.67gold quality
myocardiumUBERON:000234999.67gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450299.67gold quality
pituitary glandUBERON:000000799.66gold quality
muscle organUBERON:000163099.66gold quality
skeletal muscle organUBERON:001489299.66gold quality

Single-cell (SCXA)

Detected in 14 experiment(s), a significant marker in 7.

ExperimentMarker?Max mean expression
E-MTAB-9388yes3731.78
E-CURD-98yes2464.62
E-MTAB-9221yes48.35
E-MTAB-7316yes24.40
E-MTAB-10042yes15.31
E-HCAD-9yes8.10
E-HCAD-10no2429.77
E-MTAB-10596no2335.45
E-MTAB-10662no2310.36
E-GEOD-86618no395.11
E-HCAD-4no83.52
E-MTAB-8410no45.85
E-MTAB-8271no9.50
E-ANND-3no0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): BAP1, HCFC1, RNF2, YY1

miRNA regulators (miRDB)

6 targeting COX7C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-766-5P99.4767.912225
HSA-MIR-184398.9766.07838
HSA-MIR-4802-5P98.9766.26833
HSA-MIR-64098.4466.93644
HSA-MIR-1140190.5863.72128
HSA-MIR-598-3P89.2567.61112

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 81.8% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 1)

  • The expression level of COX7C associates with venous thromboembolism in colon cancer patients. (PMID:32653968)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_reriocox7cENSDARG00000104537
mus_musculusCox7cENSMUSG00000017778
rattus_norvegicusENSRNOG00000063840
rattus_norvegicusCox7cl1ENSRNOG00000065320
rattus_norvegicusENSRNOG00000066702
drosophila_melanogasterCOX7CFBGN0040773
caenorhabditis_eleganscox-7CWBGENE00009161

Protein

Protein identifiers

Cytochrome c oxidase subunit 7C, mitochondrialP15954 (reviewed: P15954)

Alternative names: Cytochrome c oxidase polypeptide VIIc

All UniProt accessions (2): P15954, D6R9Z7

UniProt curated annotations — full annotation on UniProt →

Function. Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix.

Subunit / interactions. Component of the cytochrome c oxidase (complex IV, CIV), a multisubunit enzyme composed of 14 subunits. The complex is composed of a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or COX4I2), COX5A, COX5B, COX6A1 (or COX6A2), COX6B1 (or COX6B2), COX6C, COX7A2 (or COX7A1), COX7B, COX7C, COX8A and COXFA4, which are encoded in the nuclear genome. The complex exists as a monomer or a dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)). Interacts with RAB5IF.

Subcellular location. Mitochondrion inner membrane.

Pathway. Energy metabolism; oxidative phosphorylation.

Similarity. Belongs to the cytochrome c oxidase VIIc family.

RefSeq proteins (1): NP_001858* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004202COX7C/Cox8Family
IPR036636COX7C/Cox8_sfHomologous_superfamily

Pfam: PF02935

UniProt features (7 total): topological domain 2, modified residue 2, transit peptide 1, chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
9I6FELECTRON MICROSCOPY2.95
9I7UELECTRON MICROSCOPY3.15
5Z62ELECTRON MICROSCOPY3.6

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P15954-F191.280.63

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 25, 25

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-5628897TP53 Regulates Metabolic Genes
R-HSA-611105Respiratory electron transport
R-HSA-9707564Cytoprotection by HMOX1
R-HSA-9864848Complex IV assembly

MSigDB gene sets: 193 (showing top): MODULE_93, HONMA_DOCETAXEL_RESISTANCE, MODULE_151, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MORF_UBE2I, MORF_HDAC1, HSIAO_HOUSEKEEPING_GENES, RODWELL_AGING_KIDNEY_NO_BLOOD_DN, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, MORF_SKP1A, GOBP_OXIDATIVE_PHOSPHORYLATION, MORF_CTBP1, GOBP_ELECTRON_TRANSPORT_CHAIN, GNF2_FBL, KEGG_HUNTINGTONS_DISEASE

GO Biological Process (4): generation of precursor metabolites and energy (GO:0006091), mitochondrial electron transport, cytochrome c to oxygen (GO:0006123), cellular respiration (GO:0045333), oxidative phosphorylation (GO:0006119)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), respiratory chain complex IV (GO:0045277), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Transcriptional Regulation by TP531
Aerobic respiration and respiratory electron transport1
Cellular response to chemical stress1
Respiratory electron transport1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
metabolic process1
aerobic electron transport chain1
mitochondrial ATP synthesis coupled electron transport1
energy derivation by oxidation of organic compounds1
aerobic respiration1
proton motive force-driven ATP synthesis1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
mitochondrion1
mitochondrial envelope1
organelle membrane1
cytochrome complex1
respiratory chain complex1
transmembrane transporter complex1
oxidoreductase complex1
cellular anatomical structure1

Protein interactions and networks

STRING

1738 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
COX7CCOX6CP09669987
COX7CCOX5BP10606983
COX7CCOX7BP24311948
COX7CCOX6B1P14854908
COX7CCOX6A1P12074846
COX7CCOX8AP10176846
COX7CCOX5AP20674839
COX7CCOX6A2Q02221810
COX7CCOXFA4O00483798
COX7CCOX7A1P24310764
COX7CNDUFA1O15239737
COX7CMT-ND5P03915736
COX7CNDUFB9Q9Y6M9725
COX7CMT-CO2P00403713
COX7CCOA6Q5JTJ3704

IntAct

23 interactions, top by confidence:

ABTypeScore
COX7CMAGEA2psi-mi:“MI:0915”(physical association)0.560
COX7CCIDEBpsi-mi:“MI:0915”(physical association)0.560
MT-CO2COX6Cpsi-mi:“MI:0915”(physical association)0.560
COX5BCOX7A2Lpsi-mi:“MI:0914”(association)0.530
COX7CE6psi-mi:“MI:0915”(physical association)0.370
K8.1EXOC5psi-mi:“MI:0914”(association)0.350
NMES1NDUFS8psi-mi:“MI:0914”(association)0.350
NDUFA4NUDT19psi-mi:“MI:0914”(association)0.350
NDUFA4NDUFS8psi-mi:“MI:0914”(association)0.350
NDUFA4COX7A2Lpsi-mi:“MI:0914”(association)0.350
repSTXBP3psi-mi:“MI:0914”(association)0.350
MAPTSHTN1psi-mi:“MI:0914”(association)0.350
COX7CCOX7A2Lpsi-mi:“MI:0914”(association)0.350
CLPPNDUFA4psi-mi:“MI:2364”(proximity)0.270
COX7CMAGEA2psi-mi:“MI:0915”(physical association)0.000
COX7CCIDEBpsi-mi:“MI:0915”(physical association)0.000

BioGRID (108): COX7C (Affinity Capture-MS), COX7C (Affinity Capture-MS), COX7C (Affinity Capture-MS), EIF3C (Positive Genetic), PGK1 (Negative Genetic), SKA3 (Positive Genetic), COX7C (Proximity Label-MS), BCAP31 (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX5A (Co-fractionation), PHB (Co-fractionation), ATP5F1 (Co-fractionation)

ESM2 similar proteins: C0HLM6, D3Z7Q2, D3ZAF6, E7EXZ6, F1MDB2, O95563, P00130, P00430, P12633, P13182, P13184, P14406, P15954, P17665, P29419, P35171, P56135, P56385, P60025, P61638, P61639, P80432, Q00361, Q01321, Q06185, Q1W0Y2, Q28851, Q2KHV4, Q3B8P0, Q53CF9, Q53CG2, Q5R4Z3, Q5R5H4, Q5RBW2, Q5XIA8, Q5XJY4, Q62425, Q7YRK5, Q8L7H8, Q8N5G0

Diamond homologs: P00430, P15954, P17665, P60025, P61638, P61639, P80334, P80432, Q1W0Y2, Q53CF9, Q53CG2, Q7YRK5, Q8SPI1, Q8SQ80, Q8SQ81

SIGNOR signaling

2 interactions.

AEffectBMechanism
YY1“up-regulates quantity by expression”COX7C“transcriptional regulation”
COX7C“form complex”“Cytochrome c oxidase-Mitochondrial respiratory chain complex IV”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 18 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Respiratory electron transport543.3×2e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

17 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance6
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

584 predictions. Top by Δscore:

VariantEffectΔscore
5:86619393:C:Gdonor_gain1.0000
5:86619443:G:GGdonor_gain1.0000
5:86619471:G:GTdonor_gain1.0000
5:86618051:GCG:Gdonor_gain0.9900
5:86619349:ACAG:Aacceptor_loss0.9900
5:86619350:CA:Cacceptor_loss0.9900
5:86619351:A:AGacceptor_gain0.9900
5:86619351:AG:Aacceptor_loss0.9900
5:86619352:G:GGacceptor_gain0.9900
5:86619352:G:Tacceptor_loss0.9900
5:86619352:GA:Gacceptor_gain0.9900
5:86619352:GAA:Gacceptor_gain0.9900
5:86619397:GATGT:Gdonor_gain0.9900
5:86619440:GTA:Gdonor_gain0.9900
5:86619441:T:TAdonor_gain0.9900
5:86619442:A:AAdonor_gain0.9900
5:86619466:A:Gdonor_gain0.9900
5:86620662:TTGCA:Tacceptor_loss0.9900
5:86620663:TGCA:Tacceptor_loss0.9900
5:86620664:GCA:Gacceptor_loss0.9900
5:86620665:CAGA:Cacceptor_loss0.9900
5:86620666:A:AGacceptor_gain0.9900
5:86620666:A:Cacceptor_loss0.9900
5:86620667:G:GGacceptor_gain0.9900
5:86620667:GAT:Gacceptor_gain0.9900
5:86620667:GATAT:Gacceptor_gain0.9900
5:86618116:G:GTdonor_gain0.9800
5:86619352:GAATT:Gacceptor_gain0.9800
5:86619466:A:AGdonor_gain0.9800
5:86618128:AAG:Adonor_loss0.9700

AlphaMissense

403 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:86619414:G:AG46E0.991
5:86619426:C:AA50D0.991
5:86619413:G:AG46R0.989
5:86619413:G:CG46R0.989
5:86619401:T:CC42R0.981
5:86619420:C:AA48E0.981
5:86619362:T:CF29L0.980
5:86619363:T:CF29S0.980
5:86619364:T:AF29L0.980
5:86619364:T:GF29L0.980
5:86619407:T:GY44D0.980
5:86619393:C:AA39D0.972
5:86618087:C:TT11I0.970
5:86619360:C:AP28Q0.962
5:86618096:T:AV14D0.960
5:86619355:T:AN26K0.959
5:86619355:T:GN26K0.959
5:86619399:T:GM41R0.958
5:86619425:G:CA50P0.958
5:86618126:G:AG24E0.953
5:86619434:T:CF53L0.953
5:86619436:C:AF53L0.953
5:86619436:C:GF53L0.953
5:86618080:T:CF9L0.948
5:86618082:C:AF9L0.948
5:86618082:C:GF9L0.948
5:86618126:G:TG24V0.948
5:86619399:T:AM41K0.948
5:86619429:C:AT51K0.947
5:86618125:G:TG24W0.946

dbSNP variants (sampled 300 via entrez): RS1000433990 (5:86618363 C>A,T), RS1000465045 (5:86618621 C>T), RS1000630921 (5:86617281 T>C), RS1000795389 (5:86617435 C>T), RS1001435985 (5:86619810 C>T), RS1002624077 (5:86619709 C>G,T), RS1002870116 (5:86616417 A>G), RS1002901137 (5:86616788 T>C), RS1003772964 (5:86621234 A>G), RS1003868323 (5:86617905 G>C,T), RS1004564099 (5:86620541 C>A), RS1005196971 (5:86618174 T>G), RS10059868 (5:86616740 T>C), RS1006209316 (5:86619012 T>C), RS1006241997 (5:86619268 G>A,C)

Disease associations

OMIM: gene MIM:603774 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002041_5Blood trace element (Cu levels)2.000000e-06
GCST006618_3Uterine fibroid size (maximum dimension)8.000000e-07

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0005267serum copper measurement
EFO:0009410uterine fibroid measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

39 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, decreases expression3
Particulate Matterdecreases expression, increases abundance, affects cotreatment3
Acetaminophenaffects cotreatment, decreases expression2
Air Pollutantsdecreases expression, increases abundance2
Doxorubicinaffects expression, increases expression2
bisphenol Fincreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
tris(2-butoxyethyl) phosphateincreases expression1
arseniteaffects binding, increases reaction1
methylparabendecreases expression1
sodium arsenitedecreases expression1
perfluorooctanoic aciddecreases expression1
ochratoxin Aincreases expression1
isobutyl alcoholincreases abundance, affects cotreatment, decreases expression1
pinosylvindecreases expression1
CGP 52608affects binding, increases reaction1
CD 437decreases expression1
chloropicrindecreases expression1
K 7174decreases expression1
3-(4’-hydroxy-3’-adamantylbiphenyl-4-yl)acrylic aciddecreases expression1
bisphenol Bincreases expression1
bisphenol AFincreases expression1
Resveratrolaffects cotreatment, increases expression1
Benzo(a)pyreneaffects methylation1
Carbamazepineaffects expression1
Estradioldecreases expression1
Fluorouracilaffects expression1
Gasolineaffects cotreatment, decreases expression, increases abundance1
Hydralazineaffects cotreatment, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.